Shimada, A., Hanafusa, T., Yasui, A., Lee, G., Taneda, Y., Sarashina, A., . . . Marquard, J. (2018). Empagliflozin as adjunct to insulin in Japanese participants with type 1 diabetes: Results of a 4‐week, double‐blind, randomized, placebo‐controlled phase 2 trial. Diabetes Obes Metab.
استشهاد بنمط شيكاغوShimada, Akira, et al. "Empagliflozin As Adjunct to Insulin in Japanese Participants With Type 1 Diabetes: Results of a 4‐week, Double‐blind, Randomized, Placebo‐controlled Phase 2 Trial." Diabetes Obes Metab 2018.
MLA استشهادShimada, Akira, et al. "Empagliflozin As Adjunct to Insulin in Japanese Participants With Type 1 Diabetes: Results of a 4‐week, Double‐blind, Randomized, Placebo‐controlled Phase 2 Trial." Diabetes Obes Metab 2018.